Associated Papers
Evaluation of Combined Chemotherapy and Genomic-Driven Targeted Therapy in Patient-Derived Xenografts Identifies New Therapeutic Approaches in Squamous Non-Small-Cell Lung Cancer Patients.
Decaudin D et al.
Cancers, 2024
39199558 (PubMed )
Supplement: cancers-16-02785-s001.zip › cancers-3122851-supplementary.pdf
Clinical Validation of a Targeted Next-Generation Sequencing Panel for Lymphoid Malignancies.
Artymiuk CJ et al.
The Journal of Molecular Diagnostics : Jmd, 2024
Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.
Matrai CE et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists, 2022
Development and Validation of Targeted Gene Sequencing Panel Based Companion Diagnostic for Korean Patients with Solid Tumors.
Min BJ et al.
Cancers, 2021
Emerging relationships between papillary proliferation of the endometrium and endometrial carcinoma: evidence from an immunohistochemical and molecular analysis.
Liu Q et al.
Virchows Archiv : an International Journal of Pathology, 2019
Genomic Comparison of Endometrioid Endometrial Carcinoma and Its Precancerous Lesions in Chinese Patients by High-Depth Next Generation Sequencing.
Wang Y et al.
Frontiers in Oncology, 2019
A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma.
Windon AL et al.
Journal of Gastrointestinal Oncology, 2018
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.
Jones S et al.
Science (new York, N.y.), 2010
Select a paper to view details